Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TGFB1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TGFB1 is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, activates. Associated with ALS, Aging, Als. Connected to 297 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TGFB1 |
| Full Name | Transforming Growth Factor Beta 1 |
| Chromosome | 19q13.2 |
| Protein Type | Ligand |
| Target Class | Ligand |
| Function | encodes Transforming Growth Factor Beta 1, a key cytokine with complex roles in neuroinflammation, neuroprotection, and synaptic plasticity |
| Mechanism of Action | Monoclonal antibodies neutralizing TGF-β1 or small molecule inhibitors of TGF-β signaling |
| Druggability | Low (0.44) |
| Clinical Stage | Phase III |
| Amino Acids | 390 aa |
| Gene Type | Protein coding |
| Pathways | Autophagy, Immune Response, Mtor, Tgf-Β |
| UniProt ID | P01137 |
| Ensembl ID | ENSG00000127616 |
| GeneCards | TGFB1 |
| Human Protein Atlas | TGFB1 |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease, Cancer |
| Known Drugs/Compounds | curcumin, resveratrol |
| Interactions | ACTB, AHR, AHSA1, ALZHEIMER, AND, APP |
| SciDEX Target | View Target Profile (8 clinical trials) |
| KG Connections | 753 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TGFB1["TGFB1"] -->|"interacts"| AHR["AHR"]
TGFB1["TGFB1"] -->|"interacts"| IL10["IL10"]
TGFB1["TGFB1"] -->|"associated"| neurodegeneration["neurodegeneration"]
TGFB1["TGFB1"] -->|"interacts"| FOXP3["FOXP3"]
AHR_1["AHR"] -->|"interacts"| TGFB1["TGFB1"]
IL10_2["IL10"] -->|"interacts"| TGFB1["TGFB1"]
FOXP3_3["FOXP3"] -->|"co discussed"| TGFB1["TGFB1"]
TNFA["TNFA"] -->|"co discussed"| TGFB1["TGFB1"]
style TGFB1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Hepatic Stellate Cells | activates | cell_type | 0.95 |
| Fibrosis | contributes_to | disease | 0.95 |
| Hsc Activation | mediates | process | 0.93 |
| Vascular Remodelling | involved_in | process | 0.90 |
| pulmonary artery smooth muscle cell proliferation | promotes | process | 0.90 |
| fibrosis | promotes | process | 0.90 |
| Tumor Fibrosis | associated_with | phenotype | 0.90 |
| HSC Activation | mediates | process | 0.90 |
| Cancer-Associated Fibroblasts | activates | cell_type | 0.90 |
| extracellular vesicles | expressed_in | cell_type | 0.90 |
| mitophagy | activates | pathway | 0.90 |
| kidney fibrosis | promotes | phenotype | 0.90 |
| Liver Fibrosis | contributes_to | disease | 0.90 |
| EMT | enhances | pathway | 0.90 |
| Hepatic Stellate Cell | activates | cell_type | 0.88 |
| Hsc Cell Line | activates | cell_type | 0.88 |
| Fibroblast Activation | promotes | process | 0.88 |
| angiogenesis | promotes | process | 0.85 |
| Myofibroblasts | associated_with | cell_type | 0.85 |
| MICROGLIA | upregulates | cell_type | 0.85 |
| senescence | regulates | process | 0.85 |
| Cellular Senescence | regulates | phenotype | 0.85 |
| Type 2 Diabetes Mellitus | biomarker_for | disease | 0.82 |
| Osimertinib resistance | enhances | disease | 0.80 |
| Fibrosis | causes | disease | 0.80 |
| EGR1 | activates | protein | 0.80 |
| PLSCR3 | activates | protein | 0.80 |
| myofibroblasts | regulates | cell_type | 0.80 |
| CCN2 | regulates | gene | 0.80 |
| Ischemic Heart Disease | biomarker_for | disease | 0.79 |
| Pulmonary Arterial Hypertension | involved_in | disease | 0.75 |
| FOXP3(lo) non-Treg cells | promotes | cell_type | 0.75 |
| Tumor | associated_with | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| Inflammation | regulates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Inflammation | associated_with | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| MAP1LC3B | associated_with | gene | 0.70 |
| IL10 | associated_with | gene | 0.70 |
| TREGS | activates | cell_type | 0.70 |
| Autophagy | associated_with | pathway | 0.70 |
| AUTOPHAGY | associated_with | gene | 0.70 |
| ATG | associated_with | gene | 0.70 |
| Cancer | expressed_in | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Inflammation | implicated_in | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| FOXO1 | upregulates | gene | 0.92 |
| FOXO1 | mediates | gene | 0.90 |
| HIF-1Α | upregulates | gene | 0.90 |
| Necroinflammation | upregulates | process | 0.90 |
| h-6a065252 | targets_gene | hypothesis | 0.90 |
| h-f9c6fa3f | targets_gene | hypothesis | 0.90 |
| PLG | activates | protein | 0.85 |
| Plasmin Activation | activates | process | 0.85 |
| high glucose | upregulates | compound | 0.85 |
| Hepatocyte | expressed_in | cell_type | 0.85 |
| h-6a065252 | targets | hypothesis | 0.80 |
| METHIONINE RESTRICTION | inhibits | biological_process | 0.80 |
| h-f9c6fa3f | targets | hypothesis | 0.80 |
| AHSA1-HSP90AA1 complex | associated_with | gene | 0.80 |
| TNF | associated_with | gene | 0.80 |
| mesenchymal stem cell | associated_with | cell_type | 0.75 |
| MIRNAS | therapeutic_target | gene | 0.70 |
| GENES | associated_with | gene | 0.70 |
| ATG | associated_with | gene | 0.70 |
| TAU | associated_with | gene | 0.65 |
| GSK3B | associated_with | gene | 0.65 |
| C1QR | activates | protein | 0.64 |
| APP | therapeutic_target | gene | 0.60 |
| IGF1R | therapeutic_target | gene | 0.60 |
| GSK3B | therapeutic_target | gene | 0.60 |
| MMP2 | therapeutic_target | gene | 0.60 |
| ESR1 | therapeutic_target | gene | 0.60 |
| TAU | therapeutic_target | gene | 0.60 |
| CD200 | associated_with | gene | 0.60 |
| NOS2 | therapeutic_target | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| CDKN2A | regulates | gene | 0.60 |
| SQSTM1 | regulates | gene | 0.60 |
| CDKN1A | regulates | gene | 0.60 |
| P62 | regulates | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| SMAD2 | activates | gene | 0.60 |
| FUNDC1 | activates | gene | 0.60 |
| SMAD3 | activates | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| FOXP3 | regulates | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| CD4 | regulates | gene | 0.60 |
| CDK5 | therapeutic_target | gene | 0.60 |
| STAT3 | implicated_in | gene | 0.60 |
| STING | associated_with | gene | 0.60 |
| JUNB | activates | gene | 0.60 |
| SIRT1 | associated_with | gene | 0.60 |
| HSP90AA1 | implicated_in | gene | 0.60 |
| CD8 | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.756
neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity